Monitoring reversible and irreversible EGFR inhibition with erlotinib and afatinib in a patient with EGFR-mutated non-small cell lung cancer (NSCLC) using sequential [ 18F]fluorothymidine (FLT-)PET::MPG.PuRe

Lokale TagsFreigabegeschichteDetailsÜbersicht

Monitoring reversible and irreversible EGFR inhibition with erlotinib and afatinib in a patient with EGFR-mutated non-small cell lung cancer (NSCLC) using sequential [ 18F]fluorothymidine (FLT-)PET

Item is Freigegeben

Lokale Tags

Name des Tags multiple_import

Name des Tags Gesamtimport 2015-05-13 10:38

Datensatz

Lokale Tags